About

David F. Ransohoff MD, one of the first gastroenterologists to also train as a clinical epidemiologist, has had a longstanding academic interest in improving methods to evaluate screening tests for cancer. In colon cancer screening, he has evaluated colonoscopy, sigmoidoscopy, stool blood tests, and recently molecular markers used in cancer screening. He has served as an advisor to the National Cancer Institute, FDA, and the US Preventive Services Task Force, and to other organizations and companies; and he has served in editorial positions with numerous journals. At UNC he has led faculty development programs for junior faculty and fellows as director of the Robert Wood Johnson Clinical Scholars Program and of NIH-funded training programs. Clinically he sees patients with general GI problems.